Back to search results

Behavioral Health Program for Nursing Facility Residents

This study is testing a behavioral health program called Interventions for Stressful Transitions in Later Life (InSTILL) for people staying in skilled nursing facilities and their care partners (a known person providing regular support). The program aims to help with life management and emotion regulation skills. Researchers want to see if the InSTILL program is practical, satisfying, and helpful. You could join if you and your care partner are both at least 18 years old, and you report symptoms of depression. The study will compare the InSTILL program to standard care. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 100 participants. Participants will be randomly assigned to receive either the InSTILL program or minimally enhanced usual care.
What's involved
Participants will complete assessments at three different times and a brief exit interview.
Compensation
Not stated in the trial record.
Follow-up
Client satisfaction will be measured immediately after the intervention. Feasibility of recruitment is measured at baseline and before the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07220486

Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners

Recruiting
NAAges 18+InterventionalTreatment
Massachusetts General Hospital
~100 participants
Updated 2025-11-10 on ClinicalTrials.gov
What's tested:Interventions for Stressful Transitions in Later Life

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Treatment Credibility
Measured over peri-intervention
+7 more outcomes measured

Conditions

Nursing Home Resident
Skilled Nursing Facility
Depression
Feasibility Studies
Caregiver

Explore related trials

Depression

NCT07220486

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Massachusetts General Hospital

    Boston, Massachusettsstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Evan Plys, PhD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

Makenna E Law, BS
[email protected]
617-643-9406
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient and care partner both aged ≥ 18 years
Patient with care partner (known person providing regular health-related, socioemotional, or practical support) willing to participate
Patient reporting depression symptoms on a screening tool (Patient Health Questionnaire)

Exclusion

Patient intended length of nursing facility stay \< 7 days
Patient evidencing more than mild impairment on a cognitive screen (Brief Interview for Mental Status)
Patient's roommate in skilled nursing facility already enrolled in study/intervention
Either patient or care partner reporting high risk of suicidality, based on a standardized safety assessment tool
Either patient or care partner participating in newly initiated psychotherapy

What this trial measures

  • Treatment Credibilityperi-intervention

    3-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 30) scores indicate greater credibility.

  • Client Satisfaction Questionnaireimmediately after the intervention

    3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.

  • Feasibility of Recruitmentbaseline, pre-intervention

    Percentage of eligible approached dyads that are enrolled into the study.

  • Feasibility of Data Collection1 month follow-up

    Percentage of all participants with no measure fully missing at follow-up.

  • Treatment Adherenceimmediately after the intervention

    Percentage of InSTILL participants completing 5/8 sessions

  • Clinician Fidelityimmediately after the intervention

    Percentage of InSTILL sessions delivered with 100% adherence on a study-specific Fidelity Checklist.

  • Adverse Events1 month follow-up

    Any adverse events related to participation in the study.

  • Treatment Acceptability Surveyimmediately after the intervention

    Percentage of InSTILL participants scoring above the scale midpoint on all 9 Treatment Acceptability Survey items (developed for the current study).